TickerFacts.

Bioventus Inc. (BVS): Cash & Equivalents

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$51.24M
As of 2025-12-31
$29.46M
As of 2026-06-27
+19.3%
3-year compound annual growth
$86.84M2020-12-31: $86.84M2021-12-31: $43.93M2022-12-31: $30.19M2023-12-31: $36.96M2024-12-31: $41.58M2025-12-31: $51.24M$51.24M
2020-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$51.24M+23.2%2026-03-05, Balance as of period end
2024-12-31$41.58M+12.5%2026-03-05, Balance as of period end
2023-12-31$36.96M+22.5%2025-03-11, Balance as of period end
2022-12-31$30.19Mn/c2024-03-12, Balance as of period end
2021-12-31$43.93M-49.4%2023-03-31, Balance as of period end
2020-12-31$86.84Mn/a2022-03-11, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Bioventus Inc. (BVS)2025-12-31$51.24M+23.2%
UFP Technologies Inc (UFPT)2025-12-31$20.30M+50.9%
AtriCure, Inc. (ATRC)2025-12-31$167.43M+36.4%
Glaukos Corp (GKOS)2025-12-31$90.81M-46.5%
NovoCure Ltd (NVCR)2025-12-31$93.55M-42.9%
Artivion, Inc. (AORT)2025-12-31$64.91M+21.4%
iRhythm Holdings, Inc. (IRTC)2025-12-31$236.01M-43.8%
Alphatec Holdings, Inc. (ATEC)2025-12-31$160.81M+15.8%
Mimedx Group, Inc. (MDXG)2025-12-31$166.12M+59.1%

Compare BVS, UFPT, ATRC, GKOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗